Singapore-based biopharmaceutical company Tessa Therapeutics has raised an $80-million financing round led by Singapore state investor Temasek Holdings, EDBI, Karst Peak Capital, Heliconia Capital Management, Heritas and other investors.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
